Home
Pivotal Data About Efficacy and Tolerability of Arcturus Therapeutics’ COVID-19 Vaccine Published in Nature Communications  

Pivotal Data About Efficacy and Tolerability of Arcturus Therapeutics’ COVID-19 Vaccine Published in Nature Communications  

Impacting News May 22, 2024

Arcturus Therapeutics COVID-19 Vaccine Published
CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (ARCT) announced that Journal Nature Communications has This content is for paid subscribers.

Please click here to subscribe or here to log in.
Impacting News
,
May 22, 2024

Other Articles